Q2 2022
Released Aug 8, 2022, before the open
10-Q filed Aug 8, 2022, 39 days after period end · 0001493152-22-021567
Q2 2022 · 10-Q
Revenue$500.00K$500.00K no prior Q2 2021 on fileno prior Q1 2022 on file
Net Income-$2.63M-$2.63M N/M vs Q2 2021N/M vs Q1 2022
EPS Diluted-$0.61-$0.61 N/M vs Q2 2021N/M vs Q1 2022
Operating Income-$3,527,531N/M
Operating Cash Flowderived-$3,046,329N/M
Free Cash Flowderived-$3,056,631—
Margins · derived
Operating margin-705.5%
Net margin-526.4%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $500.00K | — | — | $0.00 |
| Net Income | -$2.63M | -$6.81M | -$6.37M | -$3.43M |
| EPS Diluted | -$0.61 | -$0.08 | -$0.13 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR